• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients.

作者信息

Nguyen M, Watanabe H, Budson A E, Richie J P, Folkman J

机构信息

Department of Surgery, Children's Hospital, Boston, MA 02115.

出版信息

J Natl Cancer Inst. 1993 Feb 3;85(3):241-2. doi: 10.1093/jnci/85.3.241.

DOI:10.1093/jnci/85.3.241
PMID:8423630
Abstract
摘要

相似文献

1
Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients.膀胱癌患者尿液中血管生成肽碱性成纤维细胞生长因子水平升高。
J Natl Cancer Inst. 1993 Feb 3;85(3):241-2. doi: 10.1093/jnci/85.3.241.
2
Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy.膀胱癌和良性前列腺增生患者的尿碱性成纤维细胞生长因子
Br J Urol. 1995 Sep;76(3):311-4. doi: 10.1111/j.1464-410x.1995.tb07706.x.
3
Urinary basic fibroblast growth factor in bladder cancer patients. Histopathological correlation and clinical potential.
Urol Int. 2004;73(2):173-7. doi: 10.1159/000079700.
4
Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer.膀胱癌或肾癌患者尿液中类似成纤维细胞生长因子活性水平升高。
Cancer Res. 1988 Apr 15;48(8):2083-8.
5
[Basic fibroblast growth factor(bFGf/FGF-2) in urine].尿液中的碱性成纤维细胞生长因子（bFGf/FGF-2）
Nihon Rinsho. 2010 Jul;68 Suppl 7:807-9.
6
Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.骨肉瘤患者诊断时及治疗期间血液和尿液血管生成因子水平的预后影响：一项前瞻性研究
BMC Cancer. 2017 Jun 15;17(1):419. doi: 10.1186/s12885-017-3409-z.
7
High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer.患有膀胱癌的犬尿液中碱性成纤维细胞生长因子浓度较高。
J Vet Intern Med. 1996 Jul-Aug;10(4):231-4. doi: 10.1111/j.1939-1676.1996.tb02054.x.
8
Tumour angiogenesis factor in urological cancers.泌尿系统癌症中的肿瘤血管生成因子
Br J Urol. 1984 Oct;56(5):490-4.
9
Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers.
J Natl Cancer Inst. 1994 Mar 2;86(5):356-61. doi: 10.1093/jnci/86.5.356.
10
Elevated levels of basic fibroblast growth factor in the urine of clam enterocystoplasty patients.蛤肠膀胱扩大术患者尿液中碱性成纤维细胞生长因子水平升高。
J Urol. 1996 Feb;155(2):468-70.

引用本文的文献

1
AKT Isoforms in the Immune Response in Cancer.AKT 异构体在癌症免疫反应中的作用。
Curr Top Microbiol Immunol. 2022;436:349-366. doi: 10.1007/978-3-031-06566-8_15.
2
Angiogenesis-related non-coding RNAs and gastrointestinal cancer.血管生成相关的非编码RNA与胃肠道癌
Mol Ther Oncolytics. 2021 May 15;21:220-241. doi: 10.1016/j.omto.2021.04.002. eCollection 2021 Jun 25.
3
Impact of growth factor content on proliferation of mesenchymal stromal cells derived from adipose tissue.生长因子含量对脂肪来源间充质基质细胞增殖的影响。
PLoS One. 2020 Apr 16;15(4):e0230265. doi: 10.1371/journal.pone.0230265. eCollection 2020.
4
Antiangiogenic Gene Therapy in Cancer.癌症中的抗血管生成基因治疗。
Curr Genomics. 2000;1(2):117-133. doi: 10.2174/1389202003351535.
5
Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1.分析公开可用的基因组学资源，将表达 FGF-2 的膀胱癌定义为 EMT 倾向、增殖性肿瘤，其突变率低，CTLA-4、PD-1 和 PD-L1 表达水平高。
Signal Transduct Target Ther. 2017;2:16045-. doi: 10.1038/sigtrans.2016.45. Epub 2017 Mar 17.
6
Incorporating VEGF-targeted therapy in advanced urothelial cancer.将VEGF靶向治疗纳入晚期尿路上皮癌治疗中。
Ther Adv Med Oncol. 2017 Jan;9(1):33-45. doi: 10.1177/1758834016667179. Epub 2016 Sep 16.
7
FGFs: crucial factors that regulate tumour initiation and progression.成纤维细胞生长因子：调节肿瘤起始和进展的关键因子。
Cell Prolif. 2016 Aug;49(4):438-47. doi: 10.1111/cpr.12275. Epub 2016 Jul 7.
8
A place for precision medicine in bladder cancer: targeting the FGFRs.精准医学在膀胱癌中的应用：靶向 FGFR 通路。
Future Oncol. 2016 Oct;12(19):2243-63. doi: 10.2217/fon-2016-0042. Epub 2016 Jul 6.
9
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.TRC105（抗内皮糖蛋白抗体）用于晚期/转移性尿路上皮癌成人患者的II期临床试验。
Clin Genitourin Cancer. 2017 Feb;15(1):77-85. doi: 10.1016/j.clgc.2016.05.010. Epub 2016 May 27.
10
Molecular substratification of bladder cancer: moving towards individualized patient management.膀胱癌的分子分层：迈向个体化患者管理
Ther Adv Urol. 2016 Jun;8(3):215-33. doi: 10.1177/1756287216638981. Epub 2016 Mar 28.